A. Mori
Impact in
- Oncology top 5%
- Cancer-related Molecular Pathways
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Colorectal Cancer Treatments and Studies
-
- Advanced Breast Cancer Therapies
- Cancer-related cognitive impairment studies
Papers in
- Oncology 27
- Cancer Treatment and Pharmacology 10
- HER2/EGFR in Cancer Research 10
- Cancer-related Molecular Pathways 9
- Colorectal Cancer Treatments and Studies 6
- Lung Cancer Research Studies 4
-
- Advanced Breast Cancer Therapies 19
- Cancer-related cognitive impairment studies 3
- Co-authors
- Dongrui R. Lu (16 shared papers)Richard S. Finn (14 shared papers)Véronique Dièras (14 shared papers)Karen A. Gelmon (12 shared papers)Hope S. Rugo (12 shared papers)Eric Gauthier (10 shared papers)Johannes Ettl (10 shared papers)Nadia Harbeck (8 shared papers)
- Journals
- Annals of Oncology (6 papers)Cancer Research (4 papers)The Oncologist (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Clinical Oncology (2 papers)
- Partner nations
- ItalyUnited StatesCanada
In The Last Decade
A. Mori
28 papers receiving 850 citations
A. Mori's Hit Papers
Peers
Comparison fields: 5 of 55
- Oncology 680
- Pulmonary and Respiratory Medicine 729
- Genetics 213
- Cancer Research 259
- Pathology and Forensic Medicine 40
Countries citing papers authored by A. Mori
This map shows the geographic impact of A. Mori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Mori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Mori more than expected).
Fields of papers citing papers by A. Mori
This network shows the impact of papers produced by A. Mori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Mori. The network helps show where A. Mori may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Mori, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Palbociclib plus letrozole as first-line therapy in estrogen receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer with extended follow-up Hit paper breakdown → | 2019 | 286 |
| 2 | 2018 | 106 | |
| 3 | 2018 | 69 | |
| 4 | 2018 | 67 | |
| 5 | 2019 | 55 | |
| 6 | 2019 | 55 | |
| 7 | 1993 | 42 | |
| 8 | 2021 | 40 | |
| 9 | Schedule-selective biochemical modulation of 5-fluorouracil: a phase II study in advanced colorectal cancer. | 1995 | 29 |
| 10 | 2019 | 24 | |
| 11 | 2018 | 11 | |
| 12 | 2017 | 11 | |
| 13 | 2019 | 10 | |
| 14 | 2023 | 9 | |
| 15 | 2017 | 6 | |
| 16 | 2016 | 6 | |
| 17 | 2016 | 5 | |
| 18 | 1995 | 5 | |
| 19 | In vitro synergism between 5-fluorouracil and natural beta interferon in human colon carcinoma cells. | 1995 | 5 |
| 20 | 2000 | 4 |
About A. Mori
A. Mori is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Dermatology and Genetics, having authored 30 papers that have together received 860 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (19 papers), Cancer Treatment and Pharmacology (10 papers), HER2/EGFR in Cancer Research (10 papers), Cancer-related Molecular Pathways (9 papers), Colorectal Cancer Treatments and Studies (6 papers), Breast Cancer Treatment Studies (4 papers), Lung Cancer Research Studies (4 papers) and Cancer-related cognitive impairment studies (3 papers). The work is most often cited by research in Oncology (680 citations), Pulmonary and Respiratory Medicine (729 citations), Genetics (213 citations), Cancer Research (259 citations) and Pathology and Forensic Medicine (40 citations). A. Mori has collaborated with scholars based in Italy, United States and Canada. Frequent co-authors include Dongrui R. Lu, Richard S. Finn, Véronique Dièras, Karen A. Gelmon, Hope S. Rugo, Eric Gauthier, Johannes Ettl, Nadia Harbeck, Shrividya Iyer and Cynthia Huang Bartlett. Their work appears in journals such as Annals of Oncology, Cancer Research, The Oncologist, Cancer Chemotherapy and Pharmacology and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.